TipRanks
Advertisement
Advertisement

AU:BDX Stock Latest News

BCAL Diagnostics Evolves Into National Early Cancer Detection Platform
Company AnnouncementsBCAL Diagnostics Evolves Into National Early Cancer Detection Platform
11h ago
BDX
BCAL Diagnostics Clinically Validates BREASTESTplus 2 Ahead of National Launch
PremiumCompany Announcements
BCAL Diagnostics Clinically Validates BREASTESTplus 2 Ahead of National Launch
6d ago
BDX
BCAL rolls out Avantect multi-cancer blood test across Australia
PremiumCompany Announcements
BCAL rolls out Avantect multi-cancer blood test across Australia
13d ago
BDX
BCAL Diagnostics Sets October AGM, Streamlines Digital Shareholder Participation
PremiumCompany Announcements
BCAL Diagnostics Sets October AGM, Streamlines Digital Shareholder Participation
18d ago
BDX
BCAL Diagnostics distances itself from merger talk as it pursues scale and synergies
PremiumCompany Announcements
BCAL Diagnostics distances itself from merger talk as it pursues scale and synergies
26d ago
BDX
BCAL Diagnostics pushes for board shake‑up at Genetic Signatures after lifting stake
PremiumCompany AnnouncementsBCAL Diagnostics pushes for board shake‑up at Genetic Signatures after lifting stake
1M ago
BDX
BCAL Diagnostics Builds Early Cancer Detection Platform as Test Uptake Grows
Premium
Company Announcements
BCAL Diagnostics Builds Early Cancer Detection Platform as Test Uptake Grows
1M ago
BDX
BCAL Diagnostics Files Updated Corporate Governance Statement with ASX
Premium
Company Announcements
BCAL Diagnostics Files Updated Corporate Governance Statement with ASX
1M ago
BDX
BCAL Diagnostics widens early cancer platform as losses deepen and balance sheet weakens
PremiumCompany Announcements
BCAL Diagnostics widens early cancer platform as losses deepen and balance sheet weakens
1M ago
BDX
BCAL Diagnostics boosts Genetic Signatures stake to deepen diagnostics platform
PremiumCompany Announcements
BCAL Diagnostics boosts Genetic Signatures stake to deepen diagnostics platform
1M ago
BDX
BCAL Diagnostics Issues 1.5 Million Unquoted Convertible Notes
PremiumCompany Announcements
BCAL Diagnostics Issues 1.5 Million Unquoted Convertible Notes
1M ago
BDX
BCAL Diagnostics Issues 1 Million Unquoted Convertible Notes
PremiumCompany Announcements
BCAL Diagnostics Issues 1 Million Unquoted Convertible Notes
2M ago
BDX
BCAL Diagnostics to Raise Capital via Convertible Note Placement
PremiumCompany AnnouncementsBCAL Diagnostics to Raise Capital via Convertible Note Placement
2M ago
BDX
BCAL Diagnostics Clarifies Convertible Note Funding and Share Issue Capacity
Premium
Company Announcements
BCAL Diagnostics Clarifies Convertible Note Funding and Share Issue Capacity
2M ago
BDX
BCAL Diagnostics boosts cancer test rollout, secures U.S. validation and strategic investment
Premium
Company Announcements
BCAL Diagnostics boosts cancer test rollout, secures U.S. validation and strategic investment
2M ago
BDX
BCAL Diagnostics Raises Capital Via Issue of Convertible Notes
PremiumCompany Announcements
BCAL Diagnostics Raises Capital Via Issue of Convertible Notes
3M ago
BDX
BCAL Diagnostics Issues 1 Million Unquoted Convertible Notes
PremiumCompany Announcements
BCAL Diagnostics Issues 1 Million Unquoted Convertible Notes
3M ago
BDX
BCAL Diagnostics Issues 100,000 Unquoted Convertible Notes
PremiumCompany Announcements
BCAL Diagnostics Issues 100,000 Unquoted Convertible Notes
3M ago
BDX
BCAL Diagnostics to Issue 3 Million Unquoted Convertible Notes
PremiumCompany Announcements
BCAL Diagnostics to Issue 3 Million Unquoted Convertible Notes
3M ago
BDX
BCAL buys 10.2% stake in Genetic Signatures to broaden diagnostics platform
PremiumCompany AnnouncementsBCAL buys 10.2% stake in Genetic Signatures to broaden diagnostics platform
3M ago
BDX
BCAL Diagnostics secures funding to drive cancer test commercialisation through FY2027
Premium
Company Announcements
BCAL Diagnostics secures funding to drive cancer test commercialisation through FY2027
3M ago
BDX
BCAL launches blood test to monitor breast cancer recurrence
Premium
Company Announcements
BCAL launches blood test to monitor breast cancer recurrence
4M ago
BDX

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >